Updates are available Correction dated 2021-08-12
Click to view Correction: https://doi.org/10.1038/s41536-021-00157-9
-
Authors
Schwarz, Erica L. http://orcid.org/0000-0003-3219-6653
Kelly, John M. http://orcid.org/0000-0002-5865-5347
Blum, Kevin M. http://orcid.org/0000-0002-8346-629X
Hor, Kan N.
Yates, Andrew R. http://orcid.org/0000-0003-2860-6808
Zbinden, Jacob C.
Verma, Aekaansh
Lindsey, Stephanie E. http://orcid.org/0000-0002-4784-5647
Ramachandra, Abhay B.
Szafron, Jason M.
Humphrey, Jay D. http://orcid.org/0000-0003-1011-2025
Shin’oka, Toshiharu http://orcid.org/0000-0002-5173-9249
Marsden, Alison L.
Breuer, Christopher K.
-
Funding
Funding for this research was provided by:
Nationwide Children’s Hospital
Nationwide Children’s Hospital
Nationwide Children’s Hospital
Stanford University
Yale University
- License Information
-
More Information
Article History
Received: 22 October 2020
Accepted: 11 June 2021
First Online: 22 July 2021
Change Date: 12 August 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41536-021-00157-9
Competing interests
: C.K.B. is an inventor on patent/patent applications [2015252805 (Australia), 2016565483 (Japan), 855,370, 9,446,175, 9,782,522, 10,300,082, 61/987,910, 62/266,309, 62/309,285, 62/209,990, 62/936,225] submitted by Yale University and/or Nationwide Children’s Hospital that cover methods of improving the design, manufacturing, or performance of tissue-engineered vascular grafts. C.K.B. is a founder of Lyst Therapeutics. C.K.B. and T.S. have received grant support from Gunze Ltd. The remaining authors declare no competing interests.
